About
Cancer Diagnostic
Areas of Focus
Categories
DiagnosticsBoston & New England
Team (10)
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
0
As Collaborator
4
Total Enrollment
505
By Phase
EARLY_PHASE1: 1NA: 1PHASE2: 2
By Status
RECRUITING: 4
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
Today
Hover over trial bars to see details
Recent Trials
NCT06373380Collaborator
A Study of HB-202/HB-201 in People With Human Papilloma Virus 16-Positive Head and Neck Squamous Cell Cancer (HPV 16+ HNSCC)
EARLY_PHASE1Recruiting
10 participants
Started: Apr 15, 2024 · Completed: Apr 30, 2027
NCT05606133Collaborator
Circulating Human Papilloma Virus (HPV) DNA for the Screening and Surveillance of Gynecologic Cancers
NARecruiting
100 participants
Started: Aug 10, 2022 · Completed: Aug 10, 2026
NCT05268614Collaborator
Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma
PHASE2Recruiting
250 participants
Started: May 16, 2022 · Completed: Jun 30, 2032
NCT04900623Collaborator
Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study
PHASE2Recruiting
145 participants
Started: Jul 2, 2021 · Completed: Jun 1, 2032
Locations (1)
Headquarters
Waltham, MA, United States
Map
Loading map...